IL-1 alpha, IL-1 beta and psoriasis: Conflicting results in the literature. Opposite behaviour of the two cytokines in lesional or non-lesional extracts of whole skin

Journal of Biological Regulators and Homeostatic Agents

Volumn 11, Issue 4, 1997, Pages 133-136

  Bonifati, C ^a,b   Carduccf, M ^b   Mussi, A ^a,b   D'Auria, L ^a,b   Ameglio, F ^a,b  

^a Laboratory of Clinical Pathology

^b SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

Author keywords

IL 1 alpha; IL 1 beta; Plaque type psoriasis; Skin extract

Indexed keywords

CYTOKINE; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPIDERMIS CELL; FEMALE; HUMAN; HUMAN TISSUE; MALE; PSORIASIS; SKIN BIOPSY; SKIN DEFECT; SKIN DISEASE;

EID: 0031421783     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991; 127: 871-84.
2. Takematsu H, Ohta H, Tagami H. Absence of tumor necrosis factor-alpha in suction blister fluids and stratum corneum from patients with psoriasis. Arch Dermatol Res 1989; 281: 398-400.
3. Bonifati C, Carducci M, Cordiali-Fei P, et al. Correlated increases of tumor necrosis factor-alpha, interleukin-6 and granulocyte monocyte - colony stimulating factor levels in suction blister fluids and sera of psoriatic patients: relationships with disease severity. Clin Exp Dermatol 1994; 19: 383-7.
4. Cooper KD, Hammerberger C, Baadsgaard O, et al. IL-1 activity is reduced in psoriatic skin. Decreased IL-1a and increased nonfunctional IL-1. J Immunol 1990; 144: 4593-603.
5. Debets R, Hengmans JPJJ, Troost RJJ, Benner R, Prens EP. Enhanced production of biologically active interleukin-1alpha and interleukin-1beta by psoriatic epidermal cells ex vivo. evidence of increased cytosolic interleukin-1beta levels and facilitated interleukin-1 release. Eur J Immunol 1995: 1624-30.
6. Takematsu H, Tagami H. Granulocyte-macrophage colony-stimulating factor in psoriasis. Dermatologica 1990; 181: 16-20.
7. Takematsu H, Tagami H. Interleukin 2, soluble interleukin receptor, and interferon-gamma in the suction blister fluids from psoriatic skin. Arch Dermatol Res 1990; 282: 149-52.
8. Livden JK, Bjerke JR, Degre M, Matre R. The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis. Br J Dermatol 1986; 114. 217-25.
9. Bonifati C, Ameglio F, Carducci M, Sacerdoti G, Pietravalle M, Fazio M. Interleukin-1-beta, interleukin-6 and interferon-gamma in suction blister fluids of involved and uninvolved skin and sera of psoriatic patients. Acta Derm Venereol, (Stockh), 1994; 186 (Suppl).
10. Nickoloff BJ, Karabin GD, Barker JNWN, et al. Cellular localization of interleukin-8 and its inducer tumor necrosis factor in psoriasis. Am J Pathol 1991; 138: 129-40.
11. Sauder DN, Carter S, Katz SI, Oppenheim JJ. Epidermal cell production of tymocyte activatin factor (ETAF). J Invest Dermatol 1982; 79: 34-9.
12. Sauder DN. Interleukin 1. Arch Dermatol 1989; 125: 679-82.
13. Dinarello CA, Wolff SM. The role of interleukin-1 in disease.
14. Katz AM, Rosenthal D, Sauder DN. Cell adhesion molecules. Structure, function, and implication in a variety of cutaneous and other pathologic conditions. Int J Dermatol 1991; 30: 153-60.
15. Gruaz D, Didierjean L, Grassi L, Frobert Y, Dayer JM. Interleukin 1 alpha and beta in psoriatic skin: enzymoimmunoassay, immunoblot studies and effect of systemic retinoid. Dermatologica 1989; 179: 202-6.
16. Fredrikson T, Patterson U. Severe psoriasis oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44.
17. de Boer OJ, Verhagen CE, Visser A, Bos JD, Das PK. Cellular interactions and adhesion molecules in psoriatic skin. Acta Derm Venereol (Stock) 1994; 186 (Suppl.: 15-8.
18. Boxman ILA, Ruwhof C, Boerman OC, Lowik CWGM, Ponex M. Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1. Arch Dermatol Res 1996; 288: 391-8.